This results in the formation of new epitopes which are believed to trigger the primary immune response by which the autoantibodies against tTg develop.
2.
Ascomycin produces a more selective immunomodulatory effect in that it inhibits the elicitation phase of allergic contact dermatitis but does not impair the primary immune response when administered systemically.